Fred Alger Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,000
| Closed | -$388K | – | 540 |
|
|
2019
Q3 | $388K | Sell |
8,000
-16,500
| -67% | -$800K | ﹤0.01% | 379 |
|
|
2019
Q2 | $1.29M | Buy |
24,500
+2,500
| +11% | +$132K | 0.01% | 321 |
|
|
2019
Q1 | $1.16M | Sell |
22,000
-1,000
| -4% | -$52.9K | ﹤0.01% | 319 |
|
|
2018
Q4 | $944K | Buy |
23,000
+1,000
| +5% | +$41K | ﹤0.01% | 322 |
|
|
2018
Q3 | $836K | Sell |
22,000
-9,788
| -31% | -$372K | ﹤0.01% | 335 |
|
|
2018
Q2 | $1.44M | Buy |
31,788
+23,788
| +297% | +$1.08M | 0.01% | 302 |
|
|
2018
Q1 | $386K | Buy |
+8,000
| New | +$386K | ﹤0.01% | 381 |
|
|
2017
Q4 | – | Sell |
-3,000
| Closed | -$93K | – | 605 |
|
|
2017
Q3 | $93K | Sell |
3,000
-2,000
| -40% | -$62K | ﹤0.01% | 392 |
|
|
2017
Q2 | $137K | Sell |
5,000
-11,000
| -69% | -$301K | ﹤0.01% | 396 |
|
|
2017
Q1 | $590K | Buy |
16,000
+4,000
| +33% | +$148K | ﹤0.01% | 354 |
|
|
2016
Q4 | $173K | Sell |
12,000
-7,000
| -37% | -$101K | ﹤0.01% | 355 |
|
|
2016
Q3 | $438K | Buy |
19,000
+2,000
| +12% | +$46.1K | ﹤0.01% | 361 |
|
|
2016
Q2 | $282K | Buy |
+17,000
| New | +$282K | ﹤0.01% | 405 |
|
|
2016
Q1 | – | Sell |
-16,050
| Closed | -$519K | – | 615 |
|
|
2015
Q4 | $519K | Sell |
16,050
-1,800
| -10% | -$58.2K | ﹤0.01% | 432 |
|
|
2015
Q3 | $753K | Buy |
+17,850
| New | +$753K | ﹤0.01% | 403 |
|